Targeting immune suppressive neutrophils to improve cancer immunotherapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1124690

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer is the leading cause of death in Australia. Despite the recent successes of cancer immunotherapies, there is an unmet need to overcome primary unresponsiveness and acquired resistance. Today mounting evidence has accumulated that neutrophils contribute to therapy resistance by fostering tumour blood supply and an immune suppressive microenvironment. The central aim of this project is, to improve cancer immunotherapy by blocking an immune suppressive neutrophil response.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2021

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Tumour Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer | combination therapy | immune suppression | immunotherapy | neutrophils

Related Links